Zoetis Receives FDA Approval for Simparica Trio
PARSIPPANY, N.J.–(BUSINESS WIRE)–Zoetis today announced that the U.S. Food and Drug Administration (FDA) has approved Simparica TrioTM (sarolaner, moxidectin, and pyrantel chewable tablets), the first once-monthly, chewable tablet in the U.S. that delivers all-in-one protection from heartworm disease, ticks and…